Impact BioMedical Inc.
IBO
AMEX·Healthcare·Biotechnology·Mkt cap $58.2M
$0.54
▲ +12.50%
P/E
-17.31
Mkt Cap
$58.2M
52-Wk Range
$0.37–$0.83
52-Week Range
$0.37 - $0.83
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 11.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- High volatility (beta 2.8). Larger-than-normal price swings expected.
Growth
No forward estimates available
Value
Valuation data unavailable
Momentum
Stable
-4.8% over 3m
Quality
Solid
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying IBO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 7, 2026
Most recent quarter reported revenue of $3.0K (-57% YoY). Reported EPS of -$0.01. Gross margin 66.7%.
Reported EPS · last 4Q
0 of 1 beats
Q3 26
—
Revenue trend · last 2Q
—
-57%
Q1 26
Q2 26
$7.0K
$3.0K
Margins · last 2Q
Gross
66.7%
Operating
33.3%
Profit
-23300.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How IBO stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.